FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/064699 [Registered on: 22/03/2024] Trial Registered Prospectively
Last Modified On: 05/03/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Unani 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Clinical Study on Efficacy and Safety of Insufflation with Unani Formulation in The Management of Otomycosis. 
Scientific Title of Study   Clinical Study on Efficacy and Safety of Nufookh with Unani Formulation in The Management of Otomycosis. A Randomized Controlled Clinical Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Mohd Hammad Athar Ansari 
Designation  MD Scholar 
Affiliation  Hakim Syed Ziaul Hasan Government Unani Medical College And Hospital 
Address  Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital Ayush Campus Kolar Bypass Road Bhopal Madhya Pradesh Bhopal MADHYA PRADESH 462003 India

Bhopal
MADHYA PRADESH
462003
India 
Phone  9770749994  
Fax    
Email  atharhammad9994@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Arif Anees 
Designation  Associate Professor 
Affiliation  Hakim Syed Ziaul Hasan Government Unani Medical College And Hospital 
Address  Department of Ilaj Bit Tadbeer, Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital Ayush Campus Kolar Bypass Road Bhopal Madhya Pradesh Bhopal MADHYA PRADESH 462003 India

Bhopal
MADHYA PRADESH
462003
India 
Phone  7354297786  
Fax    
Email  arifanees110@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Mohd Hammad Athar Ansari 
Designation  MD Scholar 
Affiliation  Hakim Syed Ziaul Hasan Government Unani Medical College And Hospital 
Address  Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital Ayush Campus Kolar Bypass Road Bhopal Madhya Pradesh Bhopal MADHYA PRADESH 462003 India

Bhopal
MADHYA PRADESH
462003
India 
Phone  9770749994  
Fax    
Email  atharhammad9994@gmail.com  
 
Source of Monetary or Material Support  
Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital 
 
Primary Sponsor  
Name  Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital 
Address  Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital Ayush Campus Kolar Bypass Road Bhopal Madhya Pradesh 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Mohd Hammad Athar Ansari  Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital  OPD No.7 Department of Ilaj Bit Tadbeer Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital Ayush Campus Kolar Bypass Road Bhopal Madhya Pradesh 462003 Bhopal MADHYA PRADESH
Bhopal
MADHYA PRADESH 
9770749994

atharhammad9994@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Hakim Syed Ziaul Hasan Government Unani Medical College  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H619||Disorder of external ear, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Clotrimazole ear drop  2 drops of Clotrimazole ear drop three times in a day for 15 days.  
Intervention  Nufookh  Nufookh is the process in which a grounded & filtered drug blown into the patients nose, throat or any other opening of the body through a tube. Four sittings of Nufookh (drug blown into the Ear) with Unani formulation (Shib e yamani ‘Potassium Aluminium Sulphate’& Lodh pathani ‘Symplocos Racemosa’ ) in External Audiitory Canal of affected ear on 0 day, 5th day, 10th day & 15th day. The dose of the Nufookh drug will be 250mg to 500mg depending upon the size of the ear canal. 
 
Inclusion Criteria  
Age From  11.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Clinically diagnosed patient of Otomycosis
2.All gender are included 
 
ExclusionCriteria 
Details  1.Patients with any serious debilitating diseases like malignancies, tuberculosis, and other chronic granulomatous diseases.
2.Patients with immune-compromised conditions and history suggestive of fungal diseases elsewhere in the body and those on topical antifungal drops will be excluded from the study.
3.Patient suffering from any other aural pathology e.g. Chronic Suppurative Otitis Media (CSOM), Acute Suppurative Otitis Media (ASOM), Perforation of tympanic membrane, etc. will be excluded from
the study.
4.Patient who refused to give their consent 
 
Method of Generating Random Sequence   Permuted block randomization, fixed 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1.Clinical sign and symptoms
2.Clinical examination  
baseline, 5th, 10th, 15th day 
 
Secondary Outcome  
Outcome  TimePoints 
1.Post treatment examination (Smear examination by 10%KOH preparation of ear & Fungal culture of ear will be done on 30th day.  30th day 
 
Target Sample Size   Total Sample Size="44"
Sample Size from India="44" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   17/04/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Otomycosis is the fungal infection of the external ear. It is characterized by pain, itching, discharge, ear blockage, hearing loss and ringing in ear. Water entry in ear, scratching of the ear etc. produce favourable atmosphere for fungus. Fungus lodges in that area and starts growing and produces these symptoms. Sign of the Otomycosis is whitish, blackish or brownish fungus in ear. Sometimes wet blotting paper appearance also seen.Tragus tenderness and erythema are also the signs of Otomycosis. In rare cases, primarily in immuno-compromised individuals, the disease may be extensive and involve the temporal bone. Otomycosis is commonly seen in hot and humid climate. The term Otomycosis as a disease is not mentioned in Unani classical literatures , but the some clinical features of Otomycosis are described under the headings of Wajaul uzn ,Warme uzn, Dard gosh and  Sailanul nuzn  in Unani classical literature. The eminent Unani physicians like Shekh-ur-Rais Ibne Sena, Zakariya Razi and Ahmad al Hasan Aljurjani have mentioned different formulations of Nufookh in the management of various ear diseases. Nufookh is the process in which a grounded & filtered drug blown into the patient’s nose, throat or any other opening of the body through a tube. Treatment consists of thorough ear toilet to remove all discharge and epithelial debris which are conducive to the growth of fungus. It can be done by syringing, suction or mopping. broadspectrum antifungal agents include clotrimazole can be applied. Antifungal treatment should be continued for a week even after apparent cure to avoid recurrences 3 . Nufookh therapy with Unani formulation can be done. Ear must be kept clean and dry
 
Close